Lidocaine Hydrochloride

Product Name: Lidocaine Hydrochloride

Physical & Chemical Properties:

echnique(s)
CAS No
73-78-9
pplication(s)
Mol Weight
270.298
Mol FormulaC14H23ClN2O
Boiling Point350.8⁰c.
Melting Point80-82°C
Flash Point166⁰c.
Therapeutic CategoryLocal Anastatic.

What is lidocaine:
Lidocaine hydrochloride used further in formulations which are used mainly in solution / gel application for temporarily relieve pain in the mouth, throat or nose, and parts of the digestive tract. Lidocaine hydrochloride used in Parenteral application as local anaesthetics. It works by blocking nerve impulses of pain transmission to the brain. The Parenteral application Indications as local dental anaesthetic peripheral nerve blocks, caudal anaesthesia, epidural spinal anaesthesia for surgery.
Contact us for any of your requirement and /or preliminary information such as Pharmacopeia specification of an API’s Product. Customer specific test, if any shall be additionally ensured for its compliance.

Common Side effects of Lidocaine include:

  • Low blood pressure(hypotension)
  • Swelling (edema)
  • Redness at the injection site
  • Small red or purple spots on the skin
  • Skin irritation
  • Constipation
  • Nausea
  • Vomiting
  • Confusion
  • Dizziness
  • Headache
  • Numbness and tingling
  • Drowsiness
  • Tremor
  • Irritation symptoms (topicalproducts); i.e., redness, swelling

Warnings:

        This medication contains lidocaine

  • Do not take Lidocaine CV or Lidopen if you are allergic to lidocaine or any ingredients contained in this drug
  • Keep out of reach of children
  • In case of overdose, get medical help or contact a Poison Control Centerimmediately

Cautions:

  • Constant monitoring with an EKG is essentialto the proper administration of lidocaine IV; discontinue immediately with signs of excessive depression of cardiac conductivity (e.g., PR interval prolongation, QRS interval widening, arrhythmia exacerbation)
  • Lidocaine effects increased by beta-blockers and cimetidine
  • Not recommended as prophylaxis in acute myocardial infarction (MI) (controversial)
  • Liver disease, CHF, bradycardia, Wolff-Parkinson-White syndrome, marked hypoxia, severe respiratory depression, hypovolemia, incomplete heart block
  • Good for automatic and re-entrant arrhythmias, not PSVTs

 

Place Inquiry

Complete this inquiry form to Know More About our Products!